Tony Giordano
- Pharmacology top 1%
- Cholinesterase and Neurodegenerative Diseases 5
- Physiology top 2%
- Alzheimer's disease research and treatments 13
- Nitric Oxide and Endothelin Effects 7
- Biological Psychiatry top 5%
- Biochemistry top 2%
-
- RNA and protein synthesis mechanisms 5
- Ion channel regulation and function 5
- Nicotinic Acetylcholine Receptors Study 5
- RNA Interference and Gene Delivery 4
-
- Neuroscience and Neuropharmacology Research 5
- Co-authors
- Nigel H. GreigDebomoy K. LahiriHarold W. HollowayKumar SambamurtiQian-sheng YuArnold BrossiPaul S. EderChristopher G. Kevil
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Nucleic Acids Research (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- United StatesUnited KingdomIndia
In The Last Decade
Tony Giordano
45 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Pharmacology 913
- Physiology 1.0k
- Biological Psychiatry 89
- Biochemistry 245
- Computational Theory and Mathematics 472
Countries citing papers authored by Tony Giordano
This map shows the geographic impact of Tony Giordano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tony Giordano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tony Giordano more than expected).
Fields of papers citing papers by Tony Giordano
This network shows the impact of papers produced by Tony Giordano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tony Giordano. The network helps show where Tony Giordano may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tony Giordano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Abstract 16779: A Novel Hydrogen Sulfide Donor Promotes Nitric Oxide Bioavailability in a Phase I Clinical Trial | 2014 | 1 |
| 2 | 2012 | 37 | |
| 3 | 2012 | 60 | |
| 4 | 2011 | 87 | |
| 5 | 2010 | 40 | |
| 6 | 2008 | 146 | |
| 7 | 2006 | 109 | |
| 8 | 2004 | 79 | |
| 9 | 2004 | 42 | |
| 10 | 2002 | 449 | |
| 11 | 2002 | 102 | |
| 12 | 2002 | 50 | |
| 13 | 2001 | 9 | |
| 14 | 2000 | 59 | |
| 15 | 1996 | 40 | |
| 16 | 1995 | 155 | |
| 17 | 1994 | 171 | |
| 18 | 1993 | 19 | |
| 19 | 1993 | 5 | |
| 20 | 1991 | 31 |
About Tony Giordano
Tony Giordano is a scholar working on Physiology, Biochemistry and Pharmacology, having authored 45 papers that have together received 3.2k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (13 papers), Nitric Oxide and Endothelin Effects (7 papers), RNA and protein synthesis mechanisms (5 papers), Neuroscience and Neuropharmacology Research (5 papers), Cholinesterase and Neurodegenerative Diseases (5 papers), Ion channel regulation and function (5 papers), Nicotinic Acetylcholine Receptors Study (5 papers) and RNA Interference and Gene Delivery (4 papers). The work is most often cited by research in Pharmacology (913 citations), Physiology (1.0k citations) and Biological Psychiatry (89 citations). Tony Giordano has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include Nigel H. Greig, Debomoy K. Lahiri, Harold W. Holloway, Kumar Sambamurti, Qian-sheng Yu, Arnold Brossi, Paul S. Eder, Christopher G. Kevil, Jack T. Rogers and Christopher B. Pattillo. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.